Head-to-Head

Vaxcyte, Inc. Common Stock vs. Repligen Corp

PCVX

Vaxcyte, Inc. Common Stock

$55.39 -5.09%

VS RGEN

Repligen Corp

$163.81 -3.81%

Vaxcyte, Inc. Common Stock and Repligen Corp are evenly matched on the factors we track — the better pick depends on what you're optimizing for.

Size & Scale

PCVXRGEN
Market Cap $9.24 billion $10.47 billion

RGEN leads on 1 of 1 size & scale factors.

Risk & Sentiment

PCVXRGEN
Short Interest 0.13% 6.30%

PCVX leads on 1 of 1 risk & sentiment factors.

Dig deeper: PCVX overview, PCVX financials, RGEN overview, RGEN financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.